摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-氟苄氧基)苯硼酸 | 849062-13-1

中文名称
3-(2-氟苄氧基)苯硼酸
中文别名
3-(2'-氟苄氧基)苯基硼酸
英文名称
3-(2'-Fluoro-benzyl-oxy)phenyl-boronic acid
英文别名
(3-((2-Fluorobenzyl)oxy)phenyl)boronic acid;[3-[(2-fluorophenyl)methoxy]phenyl]boronic acid
3-(2-氟苄氧基)苯硼酸化学式
CAS
849062-13-1
化学式
C13H12BFO3
mdl
——
分子量
246.046
InChiKey
CPTYKSHXZNSHLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    94-106 °C(lit.)
  • 沸点:
    427.7±55.0 °C(Predicted)
  • 密度:
    1.26±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.08
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2931900090
  • 安全说明:
    S22,S24/25

SDS

SDS:8aff28191dc6c51e0edd9438500925f5
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
: 3-(2′-Fluorobenzyloxy)phenylboronic acid
Product name
CAS-No. : 849062-13-1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C13H12BFO3
Molecular Weight : 246,04 g/mol

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Toxicity reported for borates in humans: ingestion or absorption may cause nausea, vomiting, diarrhea,
abdominal cramps, anderythematous lesions on the skin and mucous membranes. Other symptoms
include: circulatory collapse, tachycardia, cyanosis, delirium, convulsions, and coma. Death has been
reported to occur in infants from less than 5 grams and in adults from 5 to 20 grams., To the best of our
knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen fluoride, Borane/boron oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Heat sensitive.
Specific end uses
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: powder
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 94 - 106 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 3,39
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
Toxicity reported for borates in humans: ingestion or absorption may cause nausea, vomiting, diarrhea,
abdominal cramps, anderythematous lesions on the skin and mucous membranes. Other symptoms
include: circulatory collapse, tachycardia, cyanosis, delirium, convulsions, and coma. Death has been
reported to occur in infants from less than 5 grams and in adults from 5 to 20 grams., To the best of our
knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    格列本脲3-(2-氟苄氧基)苯硼酸potassium phosphate monohydrate 、 palladium diacetate 、 N2Phos 作用下, 以 为溶剂, 反应 24.0h, 以73%的产率得到
    参考文献:
    名称:
    N2Phos –一种易于制备的高效配体,设计用于水中ppm级Pd催化的Suzuki-Miyaura交叉偶联
    摘要:
    一种新型的含钯芳基配体的活性钯催化剂,用于ppm级的Suzuki-Miyaura偶联,可通过胶束反应介质水溶液进行。包括芳基/杂芳基溴化物的各种各样的官能化底物是可取的,尤其是氯化物。在低钯载量(1000-2500 ppm或0.10-0.25 mol%)下,催化系统既通用又高效。密度泛函理论计算表明,在n表示更大的空间拥塞2 PHOS诱导周围的Pd中心增加空间拥挤,帮助动摇2:1配体的Pd(0)配合物更对于N 2 PHOS比EvanPhos(和体积更小的配体) ,从而有利于形成1:1配体– Pd o 在芳基氯化物的氧化加成反应中更具活性的络合物。
    DOI:
    10.1039/d0sc00968g
点击查看最新优质反应信息

文献信息

  • HandaPhos: A General Ligand Enabling Sustainable ppm Levels of Palladium-Catalyzed Cross-Couplings in Water at Room Temperature
    作者:Sachin Handa、Martin P. Andersson、Fabrice Gallou、John Reilly、Bruce H. Lipshutz
    DOI:10.1002/anie.201510570
    日期:2016.4.11
    complexed in a 1:1 ratio with Pd(OAc)2, enables Pd‐catalyzed cross‐couplings to be run using ≤1000 ppm of this pre‐catalyst. Applications to Suzuki–Miyaura reactions involving highly funtionalized reaction partners are demonstrated, all run using environmentally benign nanoreactors in water at ambient temperatures. Comparisons with existing state‐of‐the‐art ligands and catalysts are discussed herein.
    新的单膦配体HandaPhos已被鉴定为,当与Pd(OAc)2以1:1的比例络合时,可使用≤1000ppm的这种预催化剂进行Pd催化的交叉偶联。展示了在涉及高度官能化反应伙伴的Suzuki–Miyaura反应中的应用,所有反应均使用环境友好的纳米反应器在环境温度下的中进行。本文讨论了与现有最​​先进的配体和催化剂的比较。
  • Sustainable Fe–ppm Pd nanoparticle catalysis of Suzuki-Miyaura cross-couplings in water
    作者:Sachin Handa、Ye Wang、Fabrice Gallou、Bruce H. Lipshutz
    DOI:10.1126/science.aac6936
    日期:2015.9.4
    1087 An iron preparation substantially lowers the quantity of palladium needed to catalyze a common reaction that forms C-C bonds. Most of today’s use of transition metal–catalyzed cross-coupling chemistry relies on expensive quantities of palladium (Pd). Here we report that nanoparticles formed from inexpensive FeCl3 that naturally contains parts-per-million (ppm) levels of Pd can catalyze Suzuki-Miyaura
    为痕量提供动力 (Pd) 是化学催化的支柱。贵属具有锻造碳-碳 (CC) 键的诀窍。汉达等人。现在报告说,当与混合在特定制剂中时,仅百万分之一的 Pd 就足以催化形成 CC 键的 Suzuki 偶联反应。表面活性剂的加入使反应在中进行。该协议预示着在药物和农用化学品合成中保护 Pd 是个好兆头。科学,这个问题 p。1087 制剂显着降低了催化形成 CC 键的常见反应所需的量。今天大多数过渡属催化交叉偶联化学的使用依赖于昂贵数量的 (Pd)。在这里,我们报告说,由天然含有百万分之一 (ppm) 平 Pd 的廉价 FeCl3 形成的纳米粒子可以催化 Suzuki-Miyaura 反应,包括涉及极具挑战性的反应伙伴的情况。纳米胶束用于溶解反应物并将反应伙伴传递给 Fe-ppm Pd 催化剂,从而形成碳-碳键。新形成的催化剂可以在环境温度下分离和储存。含有表面活性剂和催化剂
  • A new, <i>substituted</i> palladacycle for ppm level Pd-catalyzed Suzuki–Miyaura cross couplings in water
    作者:Balaram S. Takale、Ruchita R. Thakore、Sachin Handa、Fabrice Gallou、John Reilly、Bruce H. Lipshutz
    DOI:10.1039/c9sc02528f
    日期:——
    an aqueous micellar medium, enabling valued Suzuki–Miyaura couplings to be run not only in water under mild conditions, but at 300 ppm of Pd catalyst. This general methodology has been applied to several targets in the pharmaceutical area. Multiple recyclings of the aqueous reaction mixture involving both the same as well as different coupling partners is demonstrated. Low temperature microscopy (cryo-TEM)
    新设计的环在联苯环上含有取代基以及配体 HandaPhos,与性胶束介质特别匹配,使有价值的 Suzuki-Miyaura 偶联不仅可以在温和条件下在中运行,而且可以在 300 ppm Pd 的条件下运行催化剂。这种通用方法已应用于制药领域的多个目标。证明了涉及相同和不同偶联配对物的性反应混合物的多次循环。低温显微镜 (cryo-TEM) 可显示充当纳米反应器的颗粒的性质和尺寸。重要的是,考虑到每个反应投入的负载量较低,对产品中残留的 ICP-MS 分析显示,预期平完全在 FDA 允许的限度内。
  • Simplified Preparation of ppm Pd-Containing Nanoparticles as Catalysts for Chemistry in Water
    作者:Yuting Hu、Xiaohan Li、Gongzhen Jin、Bruce H. Lipshutz
    DOI:10.1021/acscatal.3c00007
    日期:2023.3.3
    different types of couplings are studied: Suzuki–Miyaura, Sonogashira, Mizoroki–Heck, and Negishi reactions, all performed under mild aqueous micellar conditions. The simplified process relies on the initial formation of stable, storable Pd- and ligand-free NPs, to which is then added the appropriate amount of Pd(OAc)2 and ligand-matched to the desired type of coupling, in water.
    已经开发了一种协议,它不仅简化了纳米粒子 (NPs) 的制备,纳米粒子 (NPs) 含有 ppm 平的连接,影响多相催化,而且由于每种试剂的新制备性质,还确保它们可重复地提供交叉耦合的产品。研究了四种不同类型的偶联:Suzuki–Miyaura、Sonogashira、Mizoroki–Heck 和 Negishi 反应,所有反应均在温和的性胶束条件下进行。简化的过程依赖于稳定、可储存的无 Pd 和无配体 NP 的初始形成,然后在中加入适量的 Pd(OAc) 2和配体匹配到所需的偶联类型。
  • Introducing Savie: A Biodegradable Surfactant Enabling Chemo- and Biocatalysis and Related Reactions in Recyclable Water
    作者:Joseph R. A. Kincaid、Madison J. Wong、Nnamdi Akporji、Fabrice Gallou、David M. Fialho、Bruce H. Lipshutz
    DOI:10.1021/jacs.2c13444
    日期:——
    organic synthesis in recyclable water. This includes homogeneous catalysis (including examples employing only ppm levels of catalyst), heterogeneous catalysis, and biocatalytic transformations, including a multistep chemoenzymatic sequence. Use of Savie frequently leads to significantly higher yields than do conventional surfactants, while obviating the need for waste-generating organic solvents.
    Savie 是一种可生物降解的表面活性剂,源自维生素 E 和聚肌氨酸 (PSar),开发用于可循环中的有机合成。这包括均相催化(包括仅使用 ppm 级催化剂的例子)、多相催化和生物催化转化,包括多步化学酶序列。使用 Savie 通常会比传统表面活性剂产生显着更高的产率,同时无需使用产生废物的有机溶剂。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯